{"entity":{"type":"insider","cik":"0001846460","url":"/insider/0001846460","json_url":"/insider/0001846460.json","name":"Rojkjaer Lisa","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2021-11-29","last":"2023-02-28","span_basis":"filed_date"},"name_variants":[{"name":"Rojkjaer Lisa","source":"filing","n_filings":6,"first_seen":"2021-11-29","last_seen":"2023-02-28"}],"transactions":[{"id":7868136,"accession":"0001209191-23-013866","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-013866","line_url":"/filing/0001209191-23-013866#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"Viracta Therapeutics, Inc.","issuer_ticker":"VIRX","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001846460","owner_name":"Rojkjaer Lisa","owner_display_name":"Rojkjaer Lisa","owner_url":"/insider/0001846460","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2156.0,"shares_display":"2,156","price_per_share":1.6812,"price_display":"1.68","price_state":"stated","total_value":3624.6672,"total_display":"3,624.67","total_whole":"3,625","shares_owned_after":48087.0,"shares_owned_after_display":"48,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-02-28","scope":"insider"},{"id":6306594,"accession":"0001209191-22-058974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-058974","line_url":"/filing/0001209191-22-058974#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"Viracta Therapeutics, Inc.","issuer_ticker":"VIRX","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001846460","owner_name":"Rojkjaer Lisa","owner_display_name":"Rojkjaer Lisa","owner_url":"/insider/0001846460","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2116.0,"shares_display":"2,116","price_per_share":2.7193,"price_display":"2.72","price_state":"stated","total_value":5754.0388,"total_display":"5,754.04","total_whole":"5,754","shares_owned_after":46116.0,"shares_owned_after_display":"46,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-29","scope":"insider"},{"id":6657813,"accession":"0001209191-22-047951","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-047951","line_url":"/filing/0001209191-22-047951#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"Viracta Therapeutics, Inc.","issuer_ticker":"VIRX","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001846460","owner_name":"Rojkjaer Lisa","owner_display_name":"Rojkjaer Lisa","owner_url":"/insider/0001846460","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2190.0,"shares_display":"2,190","price_per_share":4.0118,"price_display":"4.01","price_state":"stated","total_value":8785.842,"total_display":"8,785.84","total_whole":"8,786","shares_owned_after":44105.0,"shares_owned_after_display":"44,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-26","filed_date":"2022-08-29","scope":"insider"},{"id":6547055,"accession":"0001209191-22-032670","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-032670","line_url":"/filing/0001209191-22-032670#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"Viracta Therapeutics, Inc.","issuer_ticker":"VIRX","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001846460","owner_name":"Rojkjaer Lisa","owner_display_name":"Rojkjaer Lisa","owner_url":"/insider/0001846460","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2154.0,"shares_display":"2,154","price_per_share":1.9011,"price_display":"1.90","price_state":"stated","total_value":4094.9694,"total_display":"4,094.97","total_whole":"4,095","shares_owned_after":42168.0,"shares_owned_after_display":"42,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-27","scope":"insider"},{"id":6750791,"accession":"0001209191-22-014441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-014441","line_url":"/filing/0001209191-22-014441#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"Viracta Therapeutics, Inc.","issuer_ticker":"VIRX","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001846460","owner_name":"Rojkjaer Lisa","owner_display_name":"Rojkjaer Lisa","owner_url":"/insider/0001846460","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2395.0,"shares_display":"2,395","price_per_share":2.7795,"price_display":"2.78","price_state":"stated","total_value":6656.9025,"total_display":"6,656.90","total_whole":"6,657","shares_owned_after":40195.0,"shares_owned_after_display":"40,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-01","scope":"insider"},{"id":5209443,"accession":"0001209191-21-067046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-067046","line_url":"/filing/0001209191-21-067046#line-3","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"Viracta Therapeutics, Inc.","issuer_ticker":"VIRX","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001846460","owner_name":"Rojkjaer Lisa","owner_display_name":"Rojkjaer Lisa","owner_url":"/insider/0001846460","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2591.0,"shares_display":"2,591","price_per_share":4.8191,"price_display":"4.82","price_state":"stated","total_value":12486.2881,"total_display":"12,486.29","total_whole":"12,486","shares_owned_after":38463.0,"shares_owned_after_display":"38,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-11-29","scope":"insider"},{"id":5209440,"accession":"0001209191-21-067046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-067046","line_url":"/filing/0001209191-21-067046#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"Viracta Therapeutics, Inc.","issuer_ticker":"VIRX","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001846460","owner_name":"Rojkjaer Lisa","owner_display_name":"Rojkjaer Lisa","owner_url":"/insider/0001846460","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1950.0,"shares_display":"1,950","price_per_share":4.8006,"price_display":"4.80","price_state":"stated","total_value":9361.17,"total_display":"9,361.17","total_whole":"9,361","shares_owned_after":41054.0,"shares_owned_after_display":"41,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001061027","name":"Viracta Therapeutics, Inc.","url":"/issuer/0001061027","role":"Officer (Chief Medical Officer)","n_filings":6,"first_seen":"2021-11-29","last_seen":"2023-02-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001846460","retrieved_at":"2026-08-24T22:40:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}